Contributions of sex chromosomal gene homologues to X monosomy

性染色体基因同源物对 X 单体的贡献

基本信息

项目摘要

Turner syndrome (TS) results from 45,X karyotype (XO), which is both the most common aneuploidy in utero (1.5%) and the single most frequent cause (~15%) of spontaneous termination. In addition to this dominant prenatal burden, TS individuals (1 in 2000 live births) suffer from short stature as well as cognitive, renal and serious cardiovascular defects. The latter span congenital heart defects and improper aortic development, which elevate the risk of fatal aortic events by almost two orders of magnitude over the general population. Collectively, cardiovascular malformations alone shorten life expectancy in the TS cohort by over a decade. Understanding the exact developmental-genetic etiology of TS is fundamental to better predicting and possibly addressing such adverse outcomes. However, neither TS-associated heart and aortic defects, nor the high termination rate of X monosomy have been mapped to specific genes to-date. Our central hypothesis is that TS results from a haploinsufficiency in a subset of homologous genes that are encoded on both sex chromosomes. The objectives of this application are to quantify the gene dosage impact of the second sex chromosome (Y or inactive X) on human induced pluripotent stem cells (hiPSCs) and differentiated smooth muscle cells (SMCs), and to narrow in on a subset of X-Y gene pairs relevant to SMC development and function. We have established otherwise isogenic hiPSCs from individuals that were mosaic for the presence of the second sex chromosome. We will compare hiPSC and SMC gene expression and differentiation potential while excluding the impact of genetic variation, and utilize both induced segmental and gene-specific deletions to dissect contributions of X-Y gene pairs. These hiPSC and derived SMC panels will enable us to identify cellular traits, genes and pathways sensitive to the presence and identity of the second sex chromosome, and help to uncover their possible impact on X monosomy and Turner syndrome. .
Turner综合征(TS)由45,X染色体核型(XO)引起,这是最常见的非整倍体, 子宫(1.5%)和自发终止的单一最常见原因(~15%)。除此之外 占主导地位的产前负担,TS个体(1/2000活产)患有身材矮小以及认知, 肾脏和严重的心血管缺陷。后者跨越先天性心脏缺陷和不适当的主动脉 发展,这将致命性主动脉事件的风险提高了近两个数量级,超过了一般的 人口总的来说,在TS队列中,仅心血管畸形就将预期寿命缩短了10%以上。 十年 了解TS的确切发育遗传病因是更好地预测和治疗TS的基础。 可能解决这种不利的结果。然而,无论是TS相关的心脏和主动脉缺陷, 迄今为止,X单体性高终止率已定位于特定基因。我们的核心假设是 TS是由两性同源基因的一个子集的单倍不足引起的, 染色体本申请的目的是量化第二性别的基因剂量影响 在人诱导多能干细胞(hiPSC)上的染色体(Y或失活X)和分化的光滑 肌肉细胞(SMC),并缩小在一个子集的X-Y基因对有关SMC的发展和 功能我们已经从个体中建立了其他方面的同基因hiPSC,这些个体因存在 第二性染色体的基因我们将比较hiPSC和SMC的基因表达和分化 潜力,同时排除遗传变异的影响,并利用诱导的节段性和基因特异性 删除以剖析X-Y基因对的贡献。这些hiPSC和衍生SMC面板将使我们能够 识别对第二性的存在和身份敏感的细胞特征、基因和途径 染色体,并帮助揭示其对X单体和特纳综合征的可能影响。 .

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stefan F. Pinter其他文献

A Tale of Two Cities: How Xist and its partners localize to and silence the bicompartmental X.

Stefan F. Pinter的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stefan F. Pinter', 18)}}的其他基金

Mechanisms of escaping X chromosome inactivation and translation to X-linked disease
逃避 X 染色体失活并转化为 X 连锁疾病的机制
  • 批准号:
    10225585
  • 财政年份:
    2017
  • 资助金额:
    $ 39.88万
  • 项目类别:

相似海外基金

Elucidating the effects of extra chromosome elimination in mosaic aneuploidy syndromes: Pallister-Killian syndrome as a model
阐明额外染色体消除对嵌合非整倍体综合征的影响:以 Pallister-Killian 综合征为模型
  • 批准号:
    10887038
  • 财政年份:
    2023
  • 资助金额:
    $ 39.88万
  • 项目类别:
Characterization of aneuploidy, cell fate and mosaicism in early development
早期发育中非整倍性、细胞命运和嵌合体的表征
  • 批准号:
    10877239
  • 财政年份:
    2023
  • 资助金额:
    $ 39.88万
  • 项目类别:
The impact of aneuploidy on early human development
非整倍体对人类早期发育的影响
  • 批准号:
    MR/X007979/1
  • 财政年份:
    2023
  • 资助金额:
    $ 39.88万
  • 项目类别:
    Research Grant
Cell competition, aneuploidy, and aging
细胞竞争、非整倍性和衰老
  • 批准号:
    10648670
  • 财政年份:
    2023
  • 资助金额:
    $ 39.88万
  • 项目类别:
Understanding how aneuploidy disrupts quiescence in the model eukaryote Saccharomyces cerevisiae
了解非整倍体如何破坏模型真核生物酿酒酵母的静止状态
  • 批准号:
    10735074
  • 财政年份:
    2023
  • 资助金额:
    $ 39.88万
  • 项目类别:
Preventing Age-Associated Oocyte Aneuploidy: Mechanisms Behind the Drosophila melanogaster Centromere Effect
预防与年龄相关的卵母细胞非整倍性:果蝇着丝粒效应背后的机制
  • 批准号:
    10538074
  • 财政年份:
    2022
  • 资助金额:
    $ 39.88万
  • 项目类别:
Functional evaluation of kinesin gene variants associated with female subfertility and egg aneuploidy.
与女性生育力低下和卵子非整倍性相关的驱动蛋白基因变异的功能评估。
  • 批准号:
    10537275
  • 财政年份:
    2022
  • 资助金额:
    $ 39.88万
  • 项目类别:
Using CRISPR screening to uncover aneuploidy-specific genetic dependencies
使用 CRISPR 筛选揭示非整倍体特异性遗传依赖性
  • 批准号:
    10661533
  • 财政年份:
    2022
  • 资助金额:
    $ 39.88万
  • 项目类别:
FASEB SRC: The Consequences of Aneuploidy: Honoring the Contributions of Angelika Amon
FASEB SRC:非整倍体的后果:纪念 Angelika Amon 的贡献
  • 批准号:
    10467260
  • 财政年份:
    2022
  • 资助金额:
    $ 39.88万
  • 项目类别:
Comparative Analysis of Aneuploidy and Cellular Fragmentation Dynamics in Mammalian Embryos
哺乳动物胚胎非整倍性和细胞破碎动力学的比较分析
  • 批准号:
    10366610
  • 财政年份:
    2022
  • 资助金额:
    $ 39.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了